Drug Development and Drug Interactions | Resources
Possible models for decision making, advisory committee meetings, presentations, preventable adverse reactions
Drug Development and Drug Interactions: Advisory Committee Meetings
Drug Development and Drug Interactions: Advisory Committee Meetings
Drug Interaction Presentations
Drug Interaction Presentations
UPDATED PUBLIC PARTICIPATION INFORMATION: January 10, 2025: Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee Meeting Announcement – 01/10/2025
January 10, 2025: Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee Meeting Announcement
FDA Clinical Investigator Training Course (CITC) 2024 – 12/10/2024
FDA Clinical Investigator Training Course (CITC) 2024
Verified Clinical Benefit | Cancer Accelerated Approvals
This listing includes accelerated approvals (AAs) for malignant hematology and oncology indications with postmarketing trials that have verified clinical benefit…
Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines approved for type 2 diabetes and obesity
Update on FDA’s ongoing evaluation of reports of suicidal thoughts or actions in patients taking a certain type of medicines…
Simultaneous detection of testosterone, nandrolone, and boldenone esters in dried blood spots for doping control in sports by liquid chromatography–tandem mass spectrometry
A simultaneous analysis methodology for 28 steroid esters (13 testosterone, nine nandrolone, and six boldenone esters) was developed using three…
Establishing effective interpretation criteria in hair analysis to distinguish between passive and active cocaine exposure: Insights from authentic hair samples collected from professional individuals exposed to cocaine
Hair analysis for detecting cocaine can be challenging due to the need to differentiate between active use and passive contamination.…